drugset / Trial / NCT02651636
Combined Therapy With Myo-inositol and Alpha-Lipoic Acid in PCOS Women
NaSingle-groupOpen-labelTreatment
Summary
The aim of our study is to investigate the effects of a combined treatment of alpha-lipoic acid and myoinositol on clinical, endocrine and metabolic features of women affected by PCOS. The study Group included 40 patients treated with a combined therapy of alpha-lipoic acid (800 mg), myoinositol (2000 mg) and folic acid (400 mcg) daily for six months. The investigation includes menstrual pattern, hirsutism score, hormonal assays, oral glucose tolerance test, lipidic profile at baseline and after six months of treatment.
Timeline
- Start
- 2014-06
- Primary completion
- 2015-07
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Inositol | Small molecule | 2000 mg | — |
| Subject | alpha-lipoic acid | Small molecule | 800 mg | — |
| Subject | folic acid | Other / unclassified | 400 ug | — |